{"schema_version":"secwatch.filing_event.v1","accession":"0001558370-23-017851","form_type":"8-K","ticker":"DWTX","cik":"0001818844","company_name":"Dogwood Therapeutics, Inc.","filed_at":"2023-11-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.654830+00:00","generated_at":"2026-06-08T16:58:21.159853+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Virios Therapeutics receives Nasdaq bid price deficiency notice; 180-day cure period","bullets":["Received Nasdaq notice on Nov 2, 2023; bid price closed below $1.00 for 30 consecutive business days.","Must regain compliance by May 1, 2023 with $1.00+ closing for 10 consecutive days.","If not compliant, may qualify for second 180-day compliance period before delisting threat.","Stock continues trading on Nasdaq Capital Market under symbol VIRI."],"urls":{"canonical":"https://secwatch.observer/filing/0001558370-23-017851","json":"https://secwatch.observer/filing/0001558370-23-017851.json","markdown":"https://secwatch.observer/filing/0001558370-23-017851.md","text":"https://secwatch.observer/filing/0001558370-23-017851.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1818844/000155837023017851/0001558370-23-017851-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1818844/000155837023017851/tmb-20231102x8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T16:58:21.159853+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"badb028c7fa17e1f87a89084c77a0a71186624d4","claim":"Dogwood Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).","evidence_excerpt":"November 2, 2023, Virios Therapeutics Inc. (the “Company”) received a letter (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, for the previous 30 consecutive business days, the bid price for the Company’s common stock had closed below the minimum $1.00 per share requirement for continued listing on The Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Bid Price Requirement”). The Notice has no effect at this time on the Company’s common stock, which continues to trade on The Nasdaq Capit","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1818844/000155837023017851/0001558370-23-017851-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}